Where Tech Meets Bio
Subscribe
Sign in
Home
Podcast
Archive
About
Latest
Top
Discussions
The Growing Relevance of Brain-Computer Interfaces & Companies Building Momentum
From invasive implants and neuroadaptive wearables to the latest AI-augmented interfaces and emerging geopolitical race...
Jul 4
•
BiopharmaTrend
and
Illia Terpylo
6
Share this post
Where Tech Meets Bio
The Growing Relevance of Brain-Computer Interfaces & Companies Building Momentum
Copy link
Facebook
Email
Notes
More
June 2025
Weekly Tech+Bio Highlights #46: New DeepMind AI Predicts How Genes Work
~$725M in Biotech Funding, UK R&D Push, & Do We Still Need Animal Testing?
Jun 27
•
BiopharmaTrend
and
Roman Kasianov
3
Share this post
Where Tech Meets Bio
Weekly Tech+Bio Highlights #46: New DeepMind AI Predicts How Genes Work
Copy link
Facebook
Email
Notes
More
Weekly Tech+Bio Highlights #45: Biotech Funding Reset & What Workers Actually Want from AI Agents
Also: Can LLMs Keep Up with Medical Experts? NHS Says AI Scribes Are Now Medical Devices; Testing Seizure Drugs on Neurons in a Dish & Building Human…
Jun 23
•
BiopharmaTrend
and
Roman Kasianov
8
Share this post
Where Tech Meets Bio
Weekly Tech+Bio Highlights #45: Biotech Funding Reset & What Workers Actually Want from AI Agents
Copy link
Facebook
Email
Notes
More
12 Startups Applying AI to Gene Editing: From Custom CRISPR to Zinc-Finger Revivals
Despite only 1% of biotech VC going to gene editing in 2024, a wave of AI-driven startups is advancing along CRISPR’s clinical milestones
Jun 20
•
BiopharmaTrend
and
Illia Terpylo
10
Share this post
Where Tech Meets Bio
12 Startups Applying AI to Gene Editing: From Custom CRISPR to Zinc-Finger Revivals
Copy link
Facebook
Email
Notes
More
Weekly Tech+Bio Highlights #44: New 9.8 Billion Protein Dataset Built for Generative Biology
Rethinking IP in the Age of AI Protein Design, Compressing Medical Images With Clinical Signal Intact, & Where AI in Drug R&D Is (and Isn’t) Gaining…
Jun 16
•
BiopharmaTrend
and
Roman Kasianov
5
Share this post
Where Tech Meets Bio
Weekly Tech+Bio Highlights #44: New 9.8 Billion Protein Dataset Built for Generative Biology
Copy link
Facebook
Email
Notes
More
1
Weekly Tech+Bio Highlights #43: New Foundation Model from MIT & Recursion
Also: Spatial Biology Means Terabyte-Scale Files, A Visual Guide to Genome Editors, Biotech VC Enters Quieter Phase, & Why AI Hallucinations May Be a…
Jun 9
•
BiopharmaTrend
and
Roman Kasianov
8
Share this post
Where Tech Meets Bio
Weekly Tech+Bio Highlights #43: New Foundation Model from MIT & Recursion
Copy link
Facebook
Email
Notes
More
1
17 More Biomedical Foundation Models
MIT & Recursion's Boltz-2 just launched—here’s a fresh scan of 15+ new models spanning chemistry, oncology, trials, and clinical workflows
Jun 7
•
BiopharmaTrend
and
Illia Terpylo
9
Share this post
Where Tech Meets Bio
17 More Biomedical Foundation Models
Copy link
Facebook
Email
Notes
More
Weekly Tech+Bio Highlights #42: Proteins, the Universe, and Everything
Neuralink's $650M Raise, Interactive Map of Digital-Pathology Deals, ASCO AI Highlights, and a 10-Year Quest to Map Cell Behavior
Jun 2
•
BiopharmaTrend
and
Roman Kasianov
7
Share this post
Where Tech Meets Bio
Weekly Tech+Bio Highlights #42: Proteins, the Universe, and Everything
Copy link
Facebook
Email
Notes
More
May 2025
14 Startups in AI Protein Design: Platforms, Specialists, Modular Tools
How a 2024’s Nobel in Chemistry, 200 million predicted structures, and $1 billion startup round shape the new fold of protein design
May 29
•
BiopharmaTrend
and
Illia Terpylo
12
Share this post
Where Tech Meets Bio
14 Startups in AI Protein Design: Platforms, Specialists, Modular Tools
Copy link
Facebook
Email
Notes
More
Weekly Tech+Bio Highlights #41: Fortnight Overview
AI Benchmarks, Models, & Gene Editing Startups—$700M+ in New Biotech Funding
May 26
•
BiopharmaTrend
and
Roman Kasianov
7
Share this post
Where Tech Meets Bio
Weekly Tech+Bio Highlights #41: Fortnight Overview
Copy link
Facebook
Email
Notes
More
AI Meets Clinical Trials: Recent Policy Shifts & Companies to Watch
Today, clinical trials are longer and more data-heavy than a decade ago. At a time of regulatory rethinking, we trace how AI is beginning to orchestrate…
May 20
•
BiopharmaTrend
7
Share this post
Where Tech Meets Bio
AI Meets Clinical Trials: Recent Policy Shifts & Companies to Watch
Copy link
Facebook
Email
Notes
More
Weekly Tech+Bio Highlights #40: FDA Sets Deadline for Internal AI Rollout
Also: Foundation Models & Drug‑Discovery Economics, Structuring Meaning for AI with Ontologies, & Emerging Startups
May 12
•
Roman Kasianov
and
BiopharmaTrend
7
Share this post
Where Tech Meets Bio
Weekly Tech+Bio Highlights #40: FDA Sets Deadline for Internal AI Rollout
Copy link
Facebook
Email
Notes
More
Share
Copy link
Facebook
Email
Notes
More
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts